2012 Q4 Form 10-Q Financial Statement

#000093976712000011 Filed on November 07, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2011 Q3
Revenue $7.814M $13.31M $128.3M
YoY Change -91.71% -89.62% 135.36%
Cost Of Revenue $0.00
YoY Change
Gross Profit $13.31M
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $9.800M $7.343M $8.200M
YoY Change 40.0% -10.45% -8.89%
% of Gross Profit 55.16%
Research & Development $32.50M $30.68M $37.47M
YoY Change 5.52% -18.11% -24.16%
% of Gross Profit 230.45%
Depreciation & Amortization $1.400M $1.500M $1.100M
YoY Change -22.22% 36.36% -54.17%
% of Gross Profit 11.27%
Operating Expenses $42.30M $38.76M $48.57M
YoY Change 11.9% -20.21% -16.83%
Operating Profit -$25.44M $79.70M
YoY Change -131.92%
Interest Expense -$10.10M $7.679M $4.142M
YoY Change 152.5% 85.39% -192.04%
% of Operating Profit 5.2%
Other Income/Expense, Net -$7.361M -$1.834M
YoY Change 301.36%
Pretax Income -$52.10M -$32.80M $77.87M
YoY Change -209.45% -142.13% -995.0%
Income Tax $100.0K $10.00K $0.00
% Of Pretax Income 0.0%
Net Earnings -$52.19M -$32.81M $77.87M
YoY Change -212.74% -142.14% -1005.41%
Net Earnings / Revenue -667.94% -246.48% 60.7%
Basic Earnings Per Share -$0.20 $0.60
Diluted Earnings Per Share -$284.3K -$0.20 $0.59
COMMON SHARES
Basic Shares Outstanding 183.6M shares 166.4M shares 129.1M shares
Diluted Shares Outstanding 166.4M shares 131.3M shares

Balance Sheet

Concept 2012 Q4 2012 Q3 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $411.4M $472.3M $223.2M
YoY Change 111.73% 111.6% 33.41%
Cash & Equivalents $170.1M $308.8M $66.21M
Short-Term Investments $241.4M $163.5M $156.9M
Other Short-Term Assets $18.30M $18.30M $17.10M
YoY Change 315.91% 7.02% -2.84%
Inventory $0.00
Prepaid Expenses
Receivables $2.800M $2.700M $4.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $432.5M $493.4M $244.9M
YoY Change 89.03% 101.47% 27.42%
LONG-TERM ASSETS
Property, Plant & Equipment $6.059M $6.292M $10.20M
YoY Change -28.77% -38.31% -45.74%
Goodwill $63.68M $63.68M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $182.3M $162.2M $85.80M
YoY Change 113.72% 89.04% -1.72%
Other Assets $8.538M $9.123M $7.100M
YoY Change 206.13% 28.49% -34.86%
Total Long-Term Assets $288.6M $269.2M $166.7M
YoY Change 75.48% 61.5% -7.75%
TOTAL ASSETS
Total Short-Term Assets $432.5M $493.4M $244.9M
Total Long-Term Assets $288.6M $269.2M $166.7M
Total Assets $721.1M $762.6M $411.6M
YoY Change 83.36% 85.28% 10.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.398M $3.246M $3.400M
YoY Change 124.73% -4.53% 17.24%
Accrued Expenses $20.56M $23.70M $49.00M
YoY Change -5.38% -51.63% -20.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.17M $13.20M $34.90M
YoY Change 170.43% -62.18% -5.93%
Total Short-Term Liabilities $81.70M $85.42M $166.6M
YoY Change -11.5% -48.73% -18.33%
LONG-TERM LIABILITIES
Long-Term Debt $322.6M $322.1M $175.1M
YoY Change 82.61% 83.95% -11.52%
Other Long-Term Liabilities $6.256M $7.768M $66.90M
YoY Change -20.24% -88.39% -64.55%
Total Long-Term Liabilities $328.8M $7.768M $242.0M
YoY Change 78.23% -96.79% -37.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.70M $85.42M $166.6M
Total Long-Term Liabilities $328.8M $7.768M $242.0M
Total Liabilities $476.0M $421.8M $408.6M
YoY Change 57.29% 3.22% -30.8%
SHAREHOLDERS EQUITY
Retained Earnings -$1.252B -$1.202B
YoY Change 13.14%
Common Stock $183.0K $183.0K
YoY Change 35.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $296.4M $340.8M $3.100M
YoY Change
Total Liabilities & Shareholders Equity $721.1M $762.6M $411.6M
YoY Change 83.36% 85.28% 10.38%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2011 Q3
OPERATING ACTIVITIES
Net Income -$52.19M -$32.81M $77.87M
YoY Change -212.74% -142.14% -1005.41%
Depreciation, Depletion And Amortization $1.400M $1.500M $1.100M
YoY Change -22.22% 36.36% -54.17%
Cash From Operating Activities -$38.70M -$34.00M -$43.30M
YoY Change 32.99% -21.48% -1.14%
INVESTING ACTIVITIES
Capital Expenditures -$1.200M -$1.000M -$100.0K
YoY Change 300.0% 900.0% -85.71%
Acquisitions
YoY Change
Other Investing Activities -$98.50M -$140.2M $32.70M
YoY Change -361.97% -528.75% -323.97%
Cash From Investing Activities -$99.70M -$141.2M $32.60M
YoY Change -367.29% -533.13% -314.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $138.4M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -400.0K 415.9M 1.700M
YoY Change 100.0% 24364.71% -158.62%
NET CHANGE
Cash From Operating Activities -38.70M -34.00M -43.30M
Cash From Investing Activities -99.70M -141.2M 32.60M
Cash From Financing Activities -400.0K 415.9M 1.700M
Net Change In Cash -138.8M 240.7M -9.000M
YoY Change -1835.0% -2774.44% -85.46%
FREE CASH FLOW
Cash From Operating Activities -$38.70M -$34.00M -$43.30M
Capital Expenditures -$1.200M -$1.000M -$100.0K
Free Cash Flow -$37.50M -$33.00M -$43.20M
YoY Change 30.21% -23.61% 0.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3246000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1957000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-8624000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-5900000 USD
CY2011Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
8943000 USD
CY2012Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
8255000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21729000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
308805000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74257000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66211000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23701000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-138000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18000 USD
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1542489000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1196992000 USD
CY2012Q3 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
4700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6172000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9284000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1893000 USD
CY2011Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2955000 USD
CY2011Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7400000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71900000 shares
CY2012Q3 us-gaap Assets
Assets
762613000 USD
CY2011Q4 us-gaap Assets
Assets
393262000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
493395000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
228824000 USD
CY2011Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
283721000 USD
CY2012Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
674708000 USD
CY2011Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
283858000 USD
CY2012Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
674727000 USD
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
118828000 USD
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
24649000 USD
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
118811000 USD
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
24639000 USD
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
555899000 USD
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
259209000 USD
CY2012Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
555897000 USD
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
259082000 USD
CY2011Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
283721000 USD
CY2012Q3 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
674708000 USD
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
173000 USD
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
103000 USD
CY2011Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
36000 USD
CY2012Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
84000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
97440000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
234548000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-31229000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135563735 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183489026 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135563735 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
183489026 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
183000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
135000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
77629000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29140000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95332000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32837000 USD
us-gaap Contracts Revenue
ContractsRevenue
16934000 USD
us-gaap Contracts Revenue
ContractsRevenue
25761000 USD
CY2011Q3 us-gaap Contracts Revenue
ContractsRevenue
5024000 USD
CY2012Q3 us-gaap Contracts Revenue
ContractsRevenue
9301000 USD
CY2011Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 USD
CY2012Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
10000000 USD
CY2011Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
91385000 USD
CY2012Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
239244000 USD
CY2012Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
389887000 USD
CY2011Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
87901000 USD
CY2012Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-54400000 USD
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
24134000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
41920000 USD
CY2012Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
16321000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4071000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5035000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 2011</font><font style="font-family:inherit;font-size:10pt;">, Accounting Standards Codification Topic 210, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet</font><font style="font-family:inherit;font-size:10pt;"> was amended to converge U.S. and international accounting standards, and requires additional disclosure about offsetting of financial instruments. This guidance will be effective </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2013</font><font style="font-family:inherit;font-size:10pt;"> and we are evaluating the effect on our consolidated financial statements.</font></div></div>
CY2011Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2011Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exelixis adopted a </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">52</font><font style="font-family:inherit;font-size:10pt;">- or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">53</font><font style="font-family:inherit;font-size:10pt;">-week fiscal year that ends on the Friday closest to December 31</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">st</sup></font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2011Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2210000 USD
CY2012Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2210000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26119000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22008000 USD
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8171000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7343000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
63684000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
63684000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
77865000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
29401000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-32804000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-95419000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3280000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2225000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-175162000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-34106000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-701000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1983000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-76000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-758000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1242000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-27082000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1522000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1892000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
35989000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-2200000 USD
CY2011Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
449000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1568000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
558000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2011Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
144000 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2012Q3 us-gaap Interest Expense
InterestExpense
7679000 USD
us-gaap Interest Expense
InterestExpense
12249000 USD
us-gaap Interest Expense
InterestExpense
15775000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
4142000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
421768000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
302630000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
393262000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
762613000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
85415000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
92325000 USD
us-gaap Licenses Revenue
LicensesRevenue
167984000 USD
CY2011Q3 us-gaap Licenses Revenue
LicensesRevenue
122703000 USD
CY2012Q3 us-gaap Licenses Revenue
LicensesRevenue
4012000 USD
us-gaap Licenses Revenue
LicensesRevenue
22702000 USD
CY2012Q3 us-gaap Long Term Investments
LongTermInvestments
162173000 USD
CY2011Q4 us-gaap Long Term Investments
LongTermInvestments
85260000 USD
CY2012Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
82885000 USD
CY2011Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
85260000 USD
CY2011Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
120005000 USD
CY2012Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
163542000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
478799000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
187668000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88838000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-159841000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-84410000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-130059000 USD
us-gaap Net Income Loss
NetIncomeLoss
-95452000 USD
us-gaap Net Income Loss
NetIncomeLoss
29401000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
77865000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-32814000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14957000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8560000 USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1834000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7361000 USD
CY2011Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4870000 USD
CY2012Q3 us-gaap Notes Payable Current
NotesPayableCurrent
3164000 USD
us-gaap Operating Expenses
OperatingExpenses
158367000 USD
us-gaap Operating Expenses
OperatingExpenses
120098000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
38756000 USD
CY2011Q3 us-gaap Operating Expenses
OperatingExpenses
48573000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
79699000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25443000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
37961000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-80462000 USD
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8423000 USD
CY2012Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8882000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2789000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9123000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-23000 USD
CY2011Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-236000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
120000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-261000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7844000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7768000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3450000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3637000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
818000 USD
CY2012Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
318000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1479000 USD
CY2011Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
98000 USD
CY2011Q4 us-gaap Other Receivables
OtherReceivables
30190000 USD
CY2012Q3 us-gaap Other Receivables
OtherReceivables
2708000 USD
CY2012Q3 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
500000 USD
CY2012Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
500000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
210580000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
359524000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
712000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1528000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4372000 USD
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6098000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
3010000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
179377000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
203479000 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
179300000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
65000000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
2589000 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6990000 USD
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-4082000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
236323000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
117244000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
877000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
828000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
987000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8506000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6292000 USD
CY2011Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
545000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
0 USD
CY2012Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
0 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
2583000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30680000 USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37465000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126058000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
96386000 USD
CY2011Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
0 USD
CY2012Q3 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
12242000 USD
CY2011Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
4199000 USD
CY2012Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
27946000 USD
us-gaap Restructuring And Related Cost Expected Cost
RestructuringAndRelatedCostExpectedCost
1300000 USD
CY2010 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
386 employee
CY2012Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Inception To Date
RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate
422 employee
CY2011Q3 us-gaap Restructuring Charges
RestructuringCharges
2937000 USD
us-gaap Restructuring Charges
RestructuringCharges
6190000 USD
us-gaap Restructuring Charges
RestructuringCharges
1704000 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
733000 USD
us-gaap Restructuring Charges
RestructuringCharges
44600000 USD
us-gaap Restructuring Costs
RestructuringCosts
-3489000 USD
us-gaap Restructuring Costs
RestructuringCosts
-3886000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
-141000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
379000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
13978000 USD
CY2012Q3 us-gaap Restructuring Reserve
RestructuringReserve
10489000 USD
CY2011Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4483000 USD
CY2012Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4033000 USD
CY2011Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
9495000 USD
CY2012Q3 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
6456000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
5363000 USD
us-gaap Restructuring Reserve Settled Without Cash
RestructuringReserveSettledWithoutCash
707000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1201809000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1106357000 USD
CY2012Q3 us-gaap Revenues
Revenues
13313000 USD
us-gaap Revenues
Revenues
39636000 USD
CY2011Q3 us-gaap Revenues
Revenues
128272000 USD
us-gaap Revenues
Revenues
196328000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6222000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9409000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
13559920 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.32
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1399526 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3300546 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
287800 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17436378 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19161690 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.84
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.16
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.12
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.92
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.49
CY2012Q3 us-gaap Share Price
SharePrice
4.25
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
239408 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M21D
CY2011Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17300000 shares
CY2012Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
12700000 shares
CY2012Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
34500000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
175708 shares
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
90632000 USD
CY2012Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
340845000 USD
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
300000 USD
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
300000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements is in conformity with GAAP, which requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, clinical trial accruals, restructuring and stock option valuation. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates.</font></div></div>
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2011Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2199000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6004000 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131344000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152316000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
166354000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129430000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152316000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166354000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123426000 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129145000 shares
CY2012Q3 exel Available For Sale Securities Debt Maturities Next Twelve Months Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesNextTwelveMonthsGrossUnrealizedGains
65000 USD
CY2011Q4 exel Available For Sale Securities Debt Maturities Next Twelve Months Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesNextTwelveMonthsGrossUnrealizedGains
24000 USD
dei Document Period End Date
DocumentPeriodEndDate
2012-09-28
dei Document Type
DocumentType
10-Q
CY2012Q3 exel Available For Sale Securities Debt Maturities Next Twelve Months Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesNextTwelveMonthsGrossUnrealizedLosses
67000 USD
CY2011Q4 exel Available For Sale Securities Debt Maturities Next Twelve Months Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesNextTwelveMonthsGrossUnrealizedLosses
151000 USD
CY2012Q3 exel Available For Sale Securities Debt Maturities Year Two Through Five Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughFiveGrossUnrealizedGains
19000 USD
CY2011Q4 exel Available For Sale Securities Debt Maturities Year Two Through Five Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughFiveGrossUnrealizedGains
12000 USD
CY2012Q3 exel Available For Sale Securities Debt Maturities Year Two Through Five Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughFiveGrossUnrealizedLosses
36000 USD
CY2011Q4 exel Available For Sale Securities Debt Maturities Year Two Through Five Gross Unrealized Losses
AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughFiveGrossUnrealizedLosses
22000 USD
exel Available For Sale Securities Unrealized Loss Position Term
AvailableForSaleSecuritiesUnrealizedLossPositionTerm
P1Y
CY2012Q3 exel Incremental Common Shares Attributable To Employee Stock Purchase Plans
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlans
0 shares
exel Incremental Common Shares Attributable To Employee Stock Purchase Plans
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlans
0 shares
CY2011Q3 exel Incremental Common Shares Attributable To Employee Stock Purchase Plans
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlans
114000 shares
exel Incremental Common Shares Attributable To Employee Stock Purchase Plans
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlans
126000 shares
exel Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
0 shares
CY2011Q3 exel Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
1444000 shares
exel Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
3471000 shares
CY2012Q3 exel Incremental Common Shares Attributable To Options
IncrementalCommonSharesAttributableToOptions
0 shares
exel Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
0 shares
CY2011Q3 exel Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
48000 shares
exel Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
281000 shares
CY2012Q3 exel Incremental Common Shares Attributable To Warrants
IncrementalCommonSharesAttributableToWarrants
0 shares
CY2012Q3 exel Payments For Underwriting Discount Debt
PaymentsForUnderwritingDiscountDebt
9300000 USD
CY2012Q3 exel Payments For Underwriting Discount Equity
PaymentsForUnderwritingDiscountEquity
7700000 USD
exel Proceeds From Convertible Debt Net
ProceedsFromConvertibleDebtNet
277673000 USD
exel Proceeds From Convertible Debt Net
ProceedsFromConvertibleDebtNet
0 USD
CY2012Q3 exel Proceeds From Convertible Debt Net
ProceedsFromConvertibleDebtNet
277700000 USD
exel Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases
ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases
901000 USD
exel Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases
ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases
11705000 USD
CY2012Q3 exel Proceeds From Issuance Of Common Stock And Convertible Debt Net
ProceedsFromIssuanceOfCommonStockAndConvertibleDebtNet
416100000 USD
CY2012Q3 exel Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
138400000 USD
exel Restructuring And Related Cost Number Of Facilities Closed
RestructuringAndRelatedCostNumberOfFacilitiesClosed
3 facility
CY2010 exel Restructuring And Related Cost Number Of Restructuring Plans
RestructuringAndRelatedCostNumberOfRestructuringPlans
2 plan
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000939767
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
183596930 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
EXELIXIS, INC.
dei Trading Symbol
TradingSymbol
exel

Files In Submission

Name View Source Status
0000939767-12-000011-index-headers.html Edgar Link pending
0000939767-12-000011-index.html Edgar Link pending
0000939767-12-000011.txt Edgar Link pending
0000939767-12-000011-xbrl.zip Edgar Link pending
exel-20120930.xml Edgar Link completed
exel-20120930.xsd Edgar Link pending
exel-20120930_cal.xml Edgar Link unprocessable
exel-20120930_def.xml Edgar Link unprocessable
exel-20120930_lab.xml Edgar Link unprocessable
exel-20120930_pre.xml Edgar Link unprocessable
exel2012093010-q.htm Edgar Link pending
exhibit31120120930.htm Edgar Link pending
exhibit31220120930.htm Edgar Link pending
exhibit32120120930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending